FOCUS Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

FOCUS Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,701	Closed	-$1.5M	–	62
2023 Q1	$1.5M	Buy	9,701 +658	+7%	+$106K	0.99%	30
2022 Q4	$1.6M	Sell	9,043 -17	-0.2%	-$2.94K	1.1%	25
2022 Q3	$1.48M	Sell	9,060 -8	-0.1%	-$1.35K	1.05%	27
2022 Q2	$1.61M	Buy	+9,068	New	+$1.62M	1.1%	22

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

FOCUS Wealth Advisors's JNJ Position: Q2 2023 in Review

FOCUS Wealth Advisors sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 9,701 shares — an estimated $1.5M sold.

FOCUS Wealth Advisors first reported a position in JNJ in Q2 2022 and held it in 4 quarters. The position peaked at $1.61M in Q2 2022. 3,754 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

FOCUS Wealth Advisors reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
FOCUS Wealth Advisors sold 9,701 Johnson & Johnson shares in Q2 2023, an estimated $1.5M.
FOCUS Wealth Advisors first reported a position in Johnson & Johnson in Q2 2022 and held it in 4 quarters.
FOCUS Wealth Advisors's Johnson & Johnson position peaked at $1.61M in Q2 2022.
3,754 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on FOCUS Wealth Advisors's 13F filing for Q2 2023, filed 14 Jul 2023.